Professor Hedley Emsley

Professional statement

Professor Hedley Emsley is a renowned consultant neurologist practising privately at the Greater Lancashire Hospital in Preston and BMI The Lancaster Hospital in Lancaster. His areas of expertise include vascular neurology, stroke, cerebrovascular disease, late-onset epilepsy, migraine and neurological disorders.

Professor Emsley graduated with an MBChB in 1996 from the University of Manchester. He undertook several junior doctor posts in the North West of England and at the National Hospital for Neurology and Neurosurgery in London before becoming a member of the Royal College of Physicians of London (MRCP) in 1999. He then completed a PhD on inflammation and cytokine regulation in stroke and undertook specialist training as a clinical lecturer in neurology at the Walton Centre for Neurology & Neurosurgery in Liverpool. Before becoming a fellow of the Royal College of Physicians of London (FRCP) in 2012, he obtained both the Certificate of Completion of Training (CCT) in neurology and a postgraduate certificate in clinical education in 2008 (PGCTLCP with distinction).

Professor Emsley was appointed Consultant Neurologist with special interest in Stroke Neurology at Lancashire Teaching Hospitals NHS Foundation Trust in 2008, and in 2014, he  became the Clinical Director for Neurology at the Trust for three years. He has several other professional responsibilities including his roles as a co-chair of the Association of British Neurologists Stroke Advisory Group and clinical advisor to the Neurology Intelligence Collaborative. He was also the external examiner for the University College London Stroke MSc programme until recently.

He took up his post as Professor of Clinical Neuroscience at Lancaster University in 2017 alongside his NHS role. He has published over 100 publications in peer-reviewed medical journals and regularly engages in peer-review and editorial work. Furthermore, he serves on the North West National Institute for Health Research (NIHR) advisory panel for the Research for Patient Benefit (RfPB) scheme and is a chief investigator and a research supervisor on a range of NIHR portfolio studies in stroke and neurological disorders.